|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/70 | |
| C07D 401/12 | |||
| C07D 403/04 | |||
| C07D 403/12 | |||
| C07D 407/12 | |||
| C07D 409/12 | |||
| C07D 409/14 | |||
| A61K 31/517 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2399909 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11166123.7 |
| Europos patento paraiškos padavimo data | 2007-07-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 818718 P | 2006-07-06 | US |
| (72) |
Mitchell, Ian, S., US
Blake, James, F., US
Xu, Rui, US
Kallan, Nicholas, C., US
Xiao, Dengming, US
Spencer, Keith, Lee, US
Bencsik, Josef, R., US
Liang, Jun, US
Safina, Brian, US
Zhang, Birong, US
Chabot, Christine, US
Do, Steven, US
Wallace, Eli, W., US
Banka, Anna, L., US
Schlachter, Stephen, T., US
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
Genentech, Inc., 1 DNA Way, South San Francisco CA 94080-4490, US |
| (54) | Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |
| Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |